Impact of symptom-to-reperfusion-time on transmural infarct extent and left ventricular strain in patients with ST-segment eleva
Authors:
Journal: European heart journal. Cardiovascular Imaging
Publication Type: Journal Article
Date: 2024
DOI: PMC10883731
ID: 37812691
Abstract
We examined the association between the symptom-to-reperfusion-time and cardiovascular magnetic resonance (CMR)-derived global strain parameters and transmural infarct extent in ST-segment elevation myocardial infarction (STEMI) patients.
Chemical List
- Contrast Media|||Gadolinium
Reference List
- Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno Het al. . 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2018;39:119–77.|||Demirkiran A, Everaars H, Amier RP, Beijnink C, Bom MJ, Gotte MJWet al. . Cardiovascular magnetic resonance techniques for tissue characterization after acute myocardial injury. Eur Heart J Cardiovasc Imaging 2019;20:723–34.|||Francone M, Bucciarelli-Ducci C, Carbone I, Canali E, Scardala R, Calabrese FAet al. . Impact of primary coronary angioplasty delay on myocardial salvage, infarct size, and microvascular damage in patients with ST-segment elevation myocardial infarction: insight from cardiovascular magnetic resonance. J Am Coll Cardiol 2009;54:2145–53.|||Hahn JY, Song YB, Gwon HC, Choe YH, Kim JH, Sung Jet al. . Relation of left ventricular infarct transmurality and infarct size after primary percutaneous coronary angioplasty to time from symptom onset to balloon inflation. Am J Cardiol 2008;102:1163–9.|||Demirkiran A, van der Hoeven NW, Janssens GN, Lemkes JS, Everaars H, van de Ven PMet al. . Left ventricular function, strain, and infarct characteristics in patients with transient ST-segment elevation myocardial infarction compared to ST-segment and non-ST-segment elevation myocardial infarctions. Eur Heart J Cardiovasc Imaging 2022;23:836–45.|||Gavara J, Rodriguez-Palomares JF, Valente F, Monmeneu JV, Lopez-Lereu MP, Bonanad Cet al. . Prognostic value of strain by tissue tracking cardiac magnetic resonance after ST-segment elevation myocardial infarction. JACC Cardiovasc Imaging 2018;11:1448–57.|||Reindl M, Tiller C, Holzknecht M, Lechner I, Beck A, Plappert Det al. . Prognostic implications of global longitudinal strain by feature-tracking cardiac magnetic resonance in ST-elevation myocardial infarction. Circulation: Cardiovascular Imaging 2019;12:e009404.|||Mangion K, Carrick D, Carberry J, Mahrous A, McComb C, Oldroyd KGet al. . Circumferential strain predicts major adverse cardiovascular events following an acute ST-segment–elevation myocardial infarction. Radiology 2019;290:329–37.|||van Leeuwen MAH, van der Hoeven NW, Janssens GN, Everaars H, Nap A, Lemkes JSet al. . Evaluation of microvascular injury in revascularized patients with ST-segment-elevation myocardial infarction treated with ticagrelor versus prasugrel. Circulation 2019;139:636–46.|||Flett AS, Hasleton J, Cook C, Hausenloy D, Quarta G, Ariti Cet al. . Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance. JACC Cardiovasc Imaging 2011;4:150–6.|||Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WKet al. . Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002;105:539–42.|||Reimer KA, Jennings RB. The “wavefront phenomenon” of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow. Lab Invest 1979;40:633–44.|||Reimer KA, Lowe JE, Rasmussen MM, Jennings RB. The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs. Circulation 1977;56:786–94.|||De Luca G, Suryapranata H, Zijlstra F, van‘t Hof AW, Hoorntje JC, Gosselink ATet al. . Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty. J Am Coll Cardiol 2003;42:991–7.|||Gersh BJ, Anderson JL. Thrombolysis and myocardial salvage. Results of clinical trials and the animal paradigm–paradoxic or predictable? Circulation 1993;88:296–306.|||de Waha S, Eitel I, Desch S, Fuernau G, Lurz P, Haznedar Det al. . Time-dependency, predictors and clinical impact of infarct transmurality assessed by magnetic resonance imaging in patients with ST-elevation myocardial infarction reperfused by primary coronary percutaneous intervention. Clin Res Cardiol 2012;101:191–200.|||Greulich S, Mayr A, Gloekler S, Seitz A, Birkmeier S, Schaufele Tet al. . Time-dependent myocardial necrosis in patients with ST-segment-elevation myocardial infarction without angiographic collateral flow visualized by cardiac magnetic resonance imaging: results from the multicenter STEMI-SCAR project. J Am Heart Assoc 2019;8:e012429.|||Ho SY. Anatomy and myoarchitecture of the left ventricular wall in normal and in disease. Eur J Echocardiogr 2009;10:iii3–7.|||Greenbaum RA, Ho SY, Gibson DG, Becker AE, Anderson RH. Left ventricular fibre architecture in man. Br Heart J 1981;45:248–63.|||Khan JN, Singh A, Nazir SA, Kanagala P, Gershlick AH, McCann GP. Comparison of cardiovascular magnetic resonance feature tracking and tagging for the assessment of left ventricular systolic strain in acute myocardial infarction. Eur J Radiol 2015;84:840–8.|||Koos R, Altiok E, Doetsch J, Neizel M, Krombach G, Marx Net al. . Layer-specific strain-encoded MRI for the evaluation of left ventricular function and infarct transmurality in patients with chronic coronary artery disease. Int J Cardiol 2013;166:85–9.|||Gerber BL. Risk area, infarct size, and the exposure of the wavefront phenomenon of myocardial necrosis in humans. Eur Heart J 2007;28:1670–2.|||Brodie BR, Webb J, Cox DA, Qureshi M, Kalynych A, Turco Met al. . Impact of time to treatment on myocardial reperfusion and infarct size with primary percutaneous coronary intervention for acute myocardial infarction (from the EMERALD trial). Am J Cardiol 2007;99:1680–6.|||De Luca G, Suryapranata H, Ottervanger JP, Antman EM. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts. Circulation 2004;109:1223–5.|||Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti Oet al. . The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343:1445–53.|||Bucius P, Erley J, Tanacli R, Zieschang V, Giusca S, Korosoglou Get al. . Comparison of feature tracking, fast-SENC, and myocardial tagging for global and segmental left ventricular strain. ESC Heart Fail 2020;7:523–32.